Precision Medicine News and Updates | Precision Medicine Online
WEBResearchers explored HER2 testing discordance, biomarkers of response, patient-reported outcomes, and the risk of lung-related disease. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
FDA Grants Full Approval to Eli Lilly's Retevmo in RET-Mutant …
WEB1 day ago — NEW YORK – The US Food and Drug Administration on Friday granted full approval to Eli Lilly's Retevmo (selpercatinib) as a treatment for certain patients with advanced RET-mutated medullary thyroid cancer. The FDA previously granted accelerated approval to the RET inhibitor in this patient ...
Case Study Suggests Role for Targeted Therapy in FGFR2 Fusion …
WEB1 day ago — NEW YORK – After seeing encouraging results in a case study, a group of researchers at Ohio State University are gearing up to more formally investigate the activity of therapies designed to target FGFR2 fusion-positive pancreatic cancer. Based on responses observed in four metastatic ...
FDA Panel Finds Limited Immunotherapy Benefit in PD-L1 …
WEB1 day ago — NEW YORK – A majority of experts in the US Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) voted on Thursday that the available data did not support the first-line use of three immunotherapies when combined with chemotherapy in gastric and esophageal cancer patients whose tumors have low or no PD-L1 expression.
AstraZeneca Nabs FDA Approval for Tagrisso in Stage III, …
WEB3 days ago — NEW YORK – The US Food and Drug Administration on Wednesday approved AstraZeneca's Tagrisso (osimertinib) for certain patients with stage III EGFR-mutated non-small cell lung cancer. The EGFR inhibitor is indicated for patients with tumors harboring exon 19 deletions or exon 21 (L858R) mutations ...
Breaking News - Precision Medicine Online
WEB4 days ago — NIH Awards $27M for Genomics-Enabled Learning Health System Network. The agency has committed $5.4 million for the first year of the five-year program to establish a network to analyze and improve how genomic information is integrated into patient care. Sep 23, 2024.
Precision Oncology News - Precision Medicine Online
WEBSep 16, 2024 — Indiana University, Indiana Biosciences Research Institute Form Precision Medicine Center. Sep 19, 2024. New Multi-Cancer Detection Data Speak to Both Promises and Cautions of Blood-Based Assays. Sep 18, 2024. Amgen's Lumakras Combo Scores High Response Rate in First-Line KRAS-Mutant Colorectal Cancer. Sep 18, 2024.
Precision Medicine in 2023: Gene Therapies Take Center Stage …
WEBNEW YORK – 2023 was undoubtedly the year of the gene therapy in precision medicine. The US Food and Drug Administration last year approved several gene therapies that for the first time promise to treat, and even cure, rare, inherited diseases of …
Genomics Research & Discovery | Precision Medicine Online
WEBAug 6, 2024 — The latest research news in genetics and genomics from Precision Medicine Online.
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
WEBJan 4, 2023 — NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Skip to content